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Gene silencing due to epigenetic mechanisms shows evidence of significant contributions to 
cancer development. We hypothesis that the genetic architecture based on retrotransposon 
elements surrounding the transcription start site, plays an important role in the suppression and 
promotion of DNA methylation. In our investigation we found a high rate of SINE and LINEs 
retrotransposon elements near the transcription start site of unmethylated genes when 
compared to methylated genes. The presence of these elements were positively associated with 
promoter methylation, contrary to logical expectations, due to the malicious effects of 
retrotransposon elements which insert themselves randomly into the genome causing possible 
loss of gene function. In our genome wide analysis of human genes, results suggested that 22% 
of the genes in cancer were predicted to be methylation-prone; in cancer these genes are 
generally down-regulated and function in the development process. In summary, our 
investigation validated our hypothesis and showed that these widespread genomic elements in 
cancer are highly associated with promoter DNA methylation and may further participate in 
influencing epigenetic regulation. 
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INTRODUCTION 
 
1.1 Epigenetics 
Previously scientist have attributed a person phenotypic’s characteristics based 
solely on the composition of the persons genomic DNA. It is through the genetic 
composition and alterations that we have studied the neoplastic evolution and were 
confounded to the idea that cancer was mainly a disease of genetics. Recently, the 
study of external influences on the DNA has come to question this idea in favor of a 
much larger complex mechanism known as epigenetics. Epigenetics was proposed by 
Conrad Waddington in the 1940’s, and originally epigenetics focused on the study of 
how genes and proteins bring phenotypes into being. Nowadays, it primarily studies the 
mechanisms of how a cell becomes committed to particular functions and how those 
functional states can be inherited in cell lineages [1]. In short it can be described as 
heritable changes in gene expression that occur without changing a single DNA 
sequence in the genome. A more concise scientific definition of epigenetics is from 
Russel et. al: “The study of mitotically and/or meritoically heritable changes in gene 
function that cannot be explained by changes in DNA sequence” [2]. 
 
Epigenetics has developed and grown in interest through the years to become a 
hot topic in biology in cancer research, scientist have found that human tumors cells may 
undergo major disruptions in the pattern of DNA methylation and histone modification [3]. 
“The aberrant epigenetic landscape of the cancer cell is characterized by a massive 
genomic hypomethylation, CpG island promoter hypermethylation of tumor suppressor 
genes, (loss of imprinting, chromatin modification), an altered histone code for critical 
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genes and a global loss of monoacetylated and trimethylated histone H4 [4]” It is these 
collective modifications that make up the human epigenome.  
 
Scientist studying epigenetics have made the analogy between the genome and 
epigenetics to the computer hardware and its software which runs the computer's 
operation. As mentioned by Dolinoy et al, "The two most extensively studied epigenetic 
mechanisms in mammals are methylation of cytosine at the carbon-5 position in CpG 
dinucleotides and chromatin packaging of DNA via histone variants and posttranslational 
histone modifications as well as subsequent nonhistone protein recruitment to specific 
regions of DNA. [5]” Dolinoy et al. further sugests  that, “Both chromatin condensation 
and DNA methylation are generally associated with gene silencing.  They are not 
necessarily independent events, but may act together to alter gene transcription. [6] " In 
addition, the aberrant epigenetic process can act as an alternative to DNA mutations to 
shut down tumor-suppressor genes and can mediate genetic alternation by inactivating 
DNA-repair genes ( e.g. DNA hypermethylation in tumorgenesis). These superimposed 
epigenetic markers on the genome are areas of interest which may allow development of 
diagnostic, treatment, and preventive models to change the instruction of such malicious 
effects. 
Through evolution the eukaryotic genome has continuously depleted itself from 
the dinueclotide CpG [7]. In the normal mammalian genome we find that the remaining 
CpG dinuclotides are methylated with a very high frequency, and this methylation in 
mammals only occurs at the 5' cytosines to guanosines. It is suspected that this 
remaining high frequency of CpG dinucleotide may help in the arrangement of chromatin 
to repress the trancription in areas of repeated regions, such as transposons and Alu 
sequences [8]. 
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1.2 CpG Islands 
 
Although, targeted for depletion and present at lower than expected frequency, 
clusters of CpG's do exist throughout the genome and are known as CpG Islands. They 
are defined as regions of DNA with GC content above 0.5 UNIT and with a high 
observed/expected frequency of the occurrence of CpG in  a region approximately 1 kb 
in length [9]. In the human genome, based on computation analysis, there are predicted 
to be around 29,000 CpG islands [10, 11], DNA Methylation and epigenetic memory and 
are usually found near the transcription start site in the promoter region of these genes. 
Previous studies have estimates of CpG island and human gene association at around 
60%, of which the vast majority are unmethylated in all tissue types and at all stages of 
development [12]. Such finding and other literature support the belief that these regions 
of DNA are 'protected' from methylation. Therefore, as stated by Baylin and Herman, 
"this lack of methylation might be a prerequisite for active transcription [13]." They 
presented two classic examples in which certain alleles of the imprinted autosomal gene 
and multiple genes in the female inactive X-chromosome had been silenced through the 
full methylation of the CpG Island in their promoter region. Classic examples such as 
these and mounting literature have shown increasing support that the methylation of 
CpG Island within promoter sequence may serve as markers in the prediction of gene 
silencing. 
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1.3 DNA Methylation Silencing 
 
Transcriptional silencing of a gene by DNA methylation of a CpG island is 
accomplished through the modification of chromatin that accompanies the base change, 
in doing so it affects structure and preventing the transcription of the gene [14]. 
 
 
 
Fig. 1. “Epigenetic modifications of DNA. Euchromatic, transcriptionally-active DNA 
becomes silenced through DNA methylation, binding of Methyl Binding Proteins (MBD) 
and recruitment of Histone deacetylase (HDAC); this sequence of reactions lead to 
histone deacetylation and chromatin condensation with formation of genes stably 
silenced for the hindrance to the binding of transcription factors. DNA methylation and 
MBD, by themselves, can also transiently modulate transcription factors binding” Figure 
1 was reproduced with PERMISSION from [15].  
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This transcriptional silencing of genes could then affect normal cell development, 
or result in abnormal cell growth. Therefore, in addition to genetic mutations, epigenetic 
silencing through DNA methylation could be viewed as an additional mechanism that 
contributes to the disruption of cell production particularly by the silencing of tumor 
suppressor genes.  
 
For nearly all cases of human cancer, the silencing of an entire tumor suppressor 
gene has been correctly shown to require Knudson's Two Hit Hypothesis [16]. To date 
most attention has been centered on two pathways that promote the disabling of tumor 
suppressor genes. The two pathways for disabling are intragenic mutations (i.e. loss of 
hetorzygosity) and loss of chromosomal material (homozygous deletion). Yet, literature 
also states transcriptional silencing may be caused through methylation of CpG Islands 
in the promoter regions of genes. Many researchers armed with the knowledge that DNA 
methylation patterns are abnormal in cancer cells, have suggested that this methylation 
abnormality in the promoter regions of tumor suppressor genes might be associated to 
human cancer [16, Figure 2].  
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Fig. 2 “Knudson’s two-hit hypothesis revised. Two active alleles of a tumor suppressor 
gene are indicated by the two green boxes shown at the top. The first step of gene 
inactivation is shown as a localized mutation on the left or by transcriptional repression 
by DNA methylation on the right. The second hit is shown by either LOH or 
transcriptional silencing” Figure 2 was reproduced with permission from [16]. 
 
As explained in the figure above, both alleles in a tumor suppressor gene must 
usually be disrupted and silenced in order to cause gene function loss [17] In Knudson's 
model, a tumor suppressor gene in sporadic cancer may lose its function for example, 
when an allele of a gene encounters a mutation (First Hit) and the other allele then 
experiences a deletion (Second Hit). Similarly, function loss of a tumor suppressor gene 
can be associated with abnormal methylation of the promoter CpG island. This occurs, 
when an allele of tumor suppressor gene is methylated and second allele experience a 
deletion. The loss of function through the mutation of both alleles is uncommon; it is 
more often the case that both alleles of a gene are inactivated through the association of 
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DNA methylation. Additionally, Knudson's model describes tumor suppressor gene 
inactivation in inherited cancer when an allele of a tumor suppressor gene suffers a 
germ line mutation, and the second becomes inavtiavted because of a chromosomal 
deletion. As described above, the second hit in inherited cancer may also be described 
in the methylation of promoter regions with high a concentration of CpG's. As a result 
there is an association which is exhibited in cancer when the loss of function is cause by 
the aberrant methylation of a gene promoter region. 
 
1.4 Retrotransposons 
 
Sequences of DNA with the ability to move within the human genome of an 
individual cell, are called transposons or transposable elements first discovered by 
Barbara McClintock, for which she was later awarded a Nobel prize in 1983. The 
process of movement for transposable elements between different locations is called 
transposition. During transposition, transposable elements can affect the genome by 
causing mutations and changing the number of bases in the DNA. These elements were 
once known as jumping genes, due to their ability to move within the genome, and are 
classic examples of what are known as mobile genetic elements. 
 
There are several mobile genetic elements, and there are thus classified based on 
their mechanism of transposition. 
• Retrotransposons are the first class (Class I) of these mobile genetic elements. 
Their method of transposition is accomplished by first transcribing itself to RNA; 
then using reverse transcriptase to reverse transcribe itself back to DNA; and 
finally, re-inserting itself into a different position in the genome. 
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• The second class of mobile genetic elements (Class II) accomplishes 
transposition using the enzyme transposase to "cut and paste" elements so that 
they will directly move from one position to another within the genome.   
 
A large portion of a eukaryote’s genome is made up transposable elements.  Initially, 
this large volume of what was thought to be useless material perplexed scientist, and 
thus label "junk DNA [18]." Further studies have shown that these elements actually do 
play important roles, amongst them development. They are indeed now viewed as useful 
information to researchers, their role in DNA alterations have provided them with many 
clues on inter workings inside the DNA of a living organism [18]. 
 
1.5 SINES AND LINES 
 
As mentioned previously, once viewed as "junk DNA" transposons have gained 
importance in recent years, specifically Class I, or retrotransposons. Within this class 
two members of the family known as SINEs and LINEs exist. There names are 
acronyms for Short Interspersed Nuclear Elements (SINEs) and Long Interspersed 
Nuclear Elements (LINEs). They are particularly important because their presence can 
lead to genetic instability [39]. Therefore, it is critical that retrotransposons remain silent, 
and a key mechanism to accomplish this is DNA methylation. 
 
In most eukaryotes these elements are the byproduct of an amplification process 
which depends on the reverse transcription of an RNA intermediate [19]. The amount of 
genome that these elements take up vary from species, from around 35% in humans [19] 
to 60% and greater in specific plants such as maize [19].  Such large amounts of 
amplification are a real threat to the host genome, since insertion of these elements into 
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new sites can bring about abnormal mutations [19]. In order to subdue such malicious 
effects, the host cells counteract transposon mobility by a combining several strategies 
to directly suppress one or several steps of these elements mobility process or on 
targeting them away from genes [19].   
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MATERIALS AND METHODS 
 
2.1 Positional Weight Matrix 
 
 Positional Weight Matrices are considered the basis of motif finding algorithm 
and are used as an algorithm to analyze and predict DNA binding sites. This common 
analysis and prediction of DNA binding sites can be divided into two problems. Problem 
one involves developing a representation of binding sites when given a collection of sites. 
These representations are then used to locate new sequences and predict the location 
where other binding sites occur. The second problem is that given a set of known 
sequences containing binding sites for a common factors (e.g. retrotransposons 
elements), but not knowing where the sites are located, one must identify the location of 
the sites in each given sequence and representation for the specificity of the protein 
[40].  In molecular biology, A major objective is to understand sequence-specific binding 
of transcription factors. A Positional weight matrix may be viewed as a way to represent 
a motif of interest. It specifies the probability of viewing a certain base of interest at each 
index position of a motif.  
 
2.2 Calculation of a Score to Predict Gene Promoter Predisposition to DNA 
Methylation 
 
The presence of SINE and LINE retrotransposons were annotated by dividing the 
promoter sequence of 36 methylation-resistant and 36 methylation-prone genes from 
into 10 bins downstream and 10 bins upstream of 1-kb sequence size for each gene’s 
transcription start site (Figure 3A/4-A).  
11 
 
Figure 3: SINE and LINE abundance score to predict gene predisposition 
tomethylation in cancer. 
 
 
 
 
 
Figure 3.” SINE and LINE abundance score to predict gene predisposition tomethylation 
in cancer. (A) Annotation of SINE and LINE retrotransposons near the promoter 
sequence of a representative methylation-prone gene (in this example, the CACNA1G 
gene). The promoter sequencewas divided into 20 bins of 1-kb sequence each (10 bins 
upstream and 10 bins downstreamof each gene TSS), and the presence of SINE and 
LINE retrotransposons was annotated for each bin. Note that each element was 
annotated to just one bin (the closest to TSS). The same procedure was followed for all 
human genes with CpG islands overlapping or no more than 200 bp from their TSS. (B) 
Example of a 20-letter acronym representing SINE retrotransposon abundance in a 
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collection of methylation-prone genes. (C) Counting of SINE presence (S) and absence 
(G) in all human genes with a promoter CpG island (genome-wide) and the training set 
ofmethylation-prone andmethylation-resistant genes. SINE abundance was converted to 
standard log-odds ratios, as described in theMethods section, and the final substitution 
matrix for SINE retrotransposons is presented (bottom table). The same calculation was 
done for LINE retrotransposons. *Transcript variant coding for the P16INK4A protein.” 
Figure 3 was reproduced with permission from [38]. 
 
 
 
 
 
Figure 4. “Graphic representation of the presence of (A) SINE and (B) LINE 
retrotransposons in each 1-kb bin from transcription start site (TSS) of methylation-prone 
and methylation-resistant genes.” Figure 4 was reproduced with permission from 
[38].  
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“Each element was annotated to a single bin based on the start site of SINE or 
LINE repeat, i.e. repeats belong to the bin in which their start sites fell. In doing so, we 
created a 20-letter acronym representation for each gene based on the presence of 
SINE and LINE. Two independent acronym sequences for SINE and LINE for each gene 
were generated; locations free of the element were marked as G representing the 
absence of that element (Figure 3B/ 4-B). Using this information we compared the 
average abundance of LINE and SINE repeat elements per bin in methylation-resistant 
and methylation-prone genes to their average abundance genomewide in the entire 
collection of human promoter CpG islands, and interpreted the preference to 
retrotransposon repeats to a score that distinguished two kinds of promoters. This score  
 
is the standard log-odd ratio which is the sum over the bin score, 
 
 
 where p,r is the background frequency for the repeat r , and qi,r is the frequency of 
observing the repeat of type r for the i-th bin for the promoters known to be methylated.  
 
To account for the low count and avoid taking logarithm of zero, qi,r  is replaced  
 
by                           derived from ‘pseudo-count’ where fr  is the fraction of the repeat that  
 
 
is type                       . 
 
N is the total number of promoters with known methylation status; Ci,r is the number of  
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repeat of type r in the i-th bin:                 . 
 
 The final value for each letter in the 20-letter acronym represent the abundance of SINE 
and LINE elements was calculated as the difference between its value in methylation-
prone and methylation-resistant genes (for example, , where Smp is the SINE standard 
log-odd ratio in methylation-prone genes and Smr is the SINE standard log-odd ratio in 
methylation-resistant genes). The calculation of the log-odd ratios for SINE elements is 
illustrated in Figure 3-C” [38].  
 
 
  
Nci,rr =∑
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RESULTS AND DISCUSSION 
 
In order to identify sequence features that are associated with the predisposition of 
DNA methylation in cancer, Dr. Marcos Estacio of the Department of Leukemia 
compared the DNA sequence promoter region in the 4-kb region surrounding the 
transcription start site of a training set. This set consisted of 36 methylation-resistant and 
36 methylation-prone genes. The methylation analysis of the promoter region for the 
genes used were accomplished through quantitative methods (bisulfate-PCR followed by 
Cobra or pyrosequencing analysis) in nine cell lines. These genes, as well as the nine 
cell lines and the peripheral blood mononuclear cell DNA from a healthy individual that 
was used as a control, can be viewed in Table 1 and 2.  
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Table 1: Training Set (reproduced with permission from [38]).
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Table 2: Methylation profile of the training set in nine cancer cell lines from 
differenttissue origin (reproduced with permission from [38]). 
 
18 
 
These particular 9 cancer lines were used because they have been identified as 
heavily methylated in previous studies [20]. Therefore, non-methylated genes found in 
these cell lines were unlikely to be found methylated elsewhere. Due to epigenetic 
modifications targeting retrotransposons to suppress their mobilization [22], we asked 
the question of whether methylation-prone genes have a different distribution of such 
elements when compared to genes that were classified as methylation resistant. As 
illustrated in Figure 5A, SINE and LINE repeats were approximately half as common in 
methylation-prone as in methylation resistant genes. Annotations of other repeats were 
analyzed but their distributions between methylation-resistant and methylation-prone 
genes were not significantly different. Other features such as GC content, CpG Island 
length, and CpG ratio have previously been shown to be associated with methylation 
status in somatic tissues (Weber et. al, 2007), yet in our observation these variables 
were not significantly different between methylation-prone and methylation-resistant 
genes in cancer. (Fig 5B)  
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Figure 5. “Distribution of repetitive elements in methylation-prone versus methylation-
resistant genes. (A) The abundance of repetitive elements of different classes was 
determined for the 4-kb sequence window centered in the TSS of 36 methylation-
resistant (white) and 36methylation-prone (black) genes. Retrotranposons of the SINE 
and LINE classes were found to be depleted in methylation-prone genes. *P < 0.02; **P 
< 0.12 (Student’s t-test). (B) Average length, GC content, and CpG ratio of CpG islands 
were not significantly different between methylation-prone and methylation-resistant 
genes. Error bars represent SEM. (C) Abundance of SINE and LINE retrotransposons in 
the 20-kb sequence window centered in the TSS of 36 methylation-prone and 36 
methylation-resistant genes. The abundance of SINE and LINE retrotransposons 
20 
 
in all promoter CpGislands in the human genomeis shown in gray. Note that the 
depletion of LINE retrotransposons is more significant in the _2-kb to +5-kb sequence 
window.” Figure 5 was reproduced with permission from [38] 
 
To investigate the effects of window size on the distribution of SINE and LINE 
retrotransposons repeats between methylation-resistant and methylation-prone genes, 
we increased our 4-kb window to a 20-kb region centered on the TSS and annotated for 
every 1-kb non-overlapping window. This analysis identified a near depletion of SINE 
repeats spanning the 20-kb region, the same did not hold for LINE repeats which only 
showed a depletion occurring mainly in the -2kb to 5 kb window (Fig 5C). For every 1-kb 
window, the log-odds score was calculated for SINE and LINE based on the full list of 
human promoter CpG Island and their distribution in the training set. Taking the sum of 
these scores in the 20-kb window enable us to measure the similarity in the distribution 
of LINE and SINE retrotransposons in an individual gene promoter in contrast to the 
average distribution of LINE and SINE in methylation-resistant and methylation-prone 
genes (Fig. 4). Using this information, we can identify three groups in the training set: (i) 
genes predicted as methylation-prone, i.e. genes depleted of both SINE and LINE, (ii) 
genes predicted to be methylation-resistant, i.e. genes enriched both SINE and LINE, 
and (iii) genes that showed enrichment of either SINE or LINE but not both. Comparing 
our results with the methylation data for each individual of the 72 observed genes 
showed that 19 of 23 (83%) genes predicted to be prone to methylation were indeed 
hypermethylated in cancer, 23 and 25 (92%) genes predicted to be methylation resistant 
were actually never or rarely hypermethylated in cancer (Fig. 6A). The 24 of 72 (34%) 
genes showing a depletion of only one type of repeat represented a class of genes of 
intermediate predisposition to methylation.  
21 
 
In order to validate our predictive method, we examined 68 methylation-resistant and 
74 methylation prone genes with available promoter methylation data in cancer (Table 3 
and 4) from a collection of tissues (Leukemia, colon, breast, and lung among others).  
Table 3: Methylation-prone genes in cancer used as test set (reproduced with 
permission from [38]).
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Table 4: Methylation-resistant genes in cancer used as test set (reproduced with 
permission from [38]). 
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As Fig. 6A displays, 92 % of genes predicted to be methylation resistant were not 
methylated, and 83% of genes predicted to be methylation prone were in fact methylated 
in cancer. Our observation also showed a 1:1 ratio of unmethylated to methylated genes 
in our predicted methylation-intermediate group. A natural extension, to validate our 
predictive method, was to test whether our model would hold in a large-scale analysis. 
For this, we compared our three classes identified by MCAM analysis, in 32 primary 
tissue and 28 cancer lines, consisting of more than 26000 probes representing around 
6600 CpG island associated gene promoters. MCAM analysis is a sensitive and specific 
micro method which is based on a selective amplification of methylated DNA after 
restriction enzyme digestion [21, 23 (explain in more detail MCAM analysis). From our 
MCAM analysis we observed that genes predicted as resistant to methylation had the 
lowest values of measured promoter methylation. Genes predicted to be methylation 
prone, however, displayed the highest average values of methylation (Fig. 6B and 6C).  
This pattern was shown in 59 of 60 (98%) genes of the studied samples (Figure 7). 
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Figure 6. “Prediction of gene predisposition and resistance to hypermethylation in 
cancer. (A) SINE and LINE scores of the training set genes. The scores were calculated 
according to the described log-odds ratio method for each gene and are represented as 
horizontal bars (white bars, SINE score; black bars, LINE score). Methylation status 
determined by bisulfite PCR methods is shown on the right. Genes with concordant 
depletion of SINE and LINE retrotransposons (log-odds) were predominantly 
methylation-prone, with the opposite found for genes with enrichment of both SINE and 
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LINE repeats. Discordant SINE and LINE scores likely represent a class of genes with 
intermediate predisposition to methylation. *Transcript variant coding for the P16INK4A 
protein. **Transcript variant coding for the P14ARF protein. Black rectangles represent 
methylated genes; white rectangles represent unmethylated genes. (B) The predictive 
method based on SINE and LINE retrotransposons abundance was applied to a test set 
composed of 142 genes. The frequency of genes correctly classified according to their 
DNA methylation status in cancer was 79% for methylation-resistant and 75% for 
methylation-prone genes. These values were closely related to those found in the 
training set (gray bars). (C ) Validation of the predictive method in a large set of cancer 
cell lines and primary cancer tissues. Methylation status of more than 6600 autosomal 
gene promoters was determined by MCAM. X chromosome genes were excluded from 
this analysis due to their hemimethylated status in female samples. The measured DNA 
methylation per tissue type was significantly higher in predicted methylation-prone genes 
than in predicted methylation-resistant and methylation-intermediate genes. Methylation 
is presented as the log2 ratio (cancer/control) of all oligonucleotide probes of a predicted 
methylation status.” Figure 6 was reproduced with permission from [38] 
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Figure 7. “Distribution of SINE, LINE and LTR repeats around the TSS of frequently 
hypermethylated and unmethylated genes identified by MCAM analysis of 28 cancer cell 
lines and 32 primary cancer tissues. The genome-wide distribution of these elements in 
CpG island promoter genes is shown in gray.” Figure 7 was reproduced with permission 
from [38]. 
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Lastly, if our model is correct, promoter CpG islands subjected to age-related 
methylation, which accounts for a large fraction of promoter CGI methylation observed in 
cancer [24], should also be depleted of SINE and LINE retrotransposons. To test this we 
compared the distribution of SINE and LINE elements in the 20-kb region surrounding 
the TSS of more than 6000 promoter CpG islands, that were identified as non-
methylated and methylated in young (3 months old) and old (35 months old) mice small 
intestine tissue by MCAM analysis.  
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Figure 8. Frequency of retroelements in methylation-prone and methylation-resistant 
genes identified in mouse cancer models and old mice. (A) Depletion of SINE and LTR 
but not LINE repeats near TSSmarks methylated promoter CpG islands in a mouse 
model ofmyelodysplastic syndrome (MDS). Bone marrow samples of three NUP98-
HOXD13 transgene animals that developed MDS (Lin et al. 2005) were studied by 
MCAM. Bone marrow samples from nontransgene animal of the same mouse strain was 
used as control, and the methylation status of approximately 6000 CpG island promoter 
genes was determined in the MCAM experiments. (B,C ) The same pattern of 
retroelements depletion is observed in hypermethylated genes in CLL (Chen et al. 2009) 
and intestinal cancer mouse models (Hahn et al. 2008). (D) Depletion of SINE, LINE, 
and LTR repeats near TSS also marks age-related methylation promoter CpG islands. 
Small intestine tissue harvested from young (3-mo-old) and old (35-mo-old) C57BL/6J 
mice were used in MCAM experiments to identify age-related methylation. Figure 8 was 
reproduced with permission from [38]. 
 
As displayed in Fig. 8, the results were similar to humans, just as human promoter 
CpG islands predisposed  to methylation in cancer, age-related methylated mouse 
promoter CpG islands were also depleted of SINE and LINE repeats. Therefore, our 
data suggest that predisposition to methylation in cancer and aging can be predicted 
based on the distribution of such elements and that genes that show this predisposition 
contain a common genome architecture marked by these elements.  
 
The promising results of our predictive model lead us to apply it genome wide. Using 
the NCBI build 36.1, we had 25,489 unique RefSeq genes, of these genes 16166 or 
about 63.4% had a promoter CpG island. From these 16166 genes, 3664 or 22.7% were 
indicated by our predictive model to be prone to methylation (methylation-prone), 7328 
or 45.3% of genes were indicated to be moderately predisposed to methylation 
(methylation-intermediate), and the rest of the 5714 or 32% of genes were predicted as 
resistant to methylation (methylation-resistant). This description is illustrated by Fig. 9. 
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Figure 9: “Genome-wide prediction of predisposition to DNA methylation in cancer. (A) 
The pie chart shows the number of RefSeq genes with no CpG islands (dark gray) and 
the number of predicted methylation-resistant (white), methylation-intermediate (light 
gray), and methylation-prone (black) genes in promoter CpG island genes. (B) Gene 
Ontology (GO) analysis of 1952 predicted methylation-prone and 2583 
predictedmethylation-resistant genes for which functional information was available. 
Horizontal bars represent the frequency of significant GO terms. (C ) Gene expression 
analysis for 2822 promoter CpG island associated genes predicted methylation-prone 
and 3651 predicted methylation-resistant genes in normal tissues. Expression values 
were retrieved from the GNF database (Su et al. 2004) and Z-score normalized per 
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tissue. Each bar represents the mean 6 SEM expression values in each tissue according 
to their predicted methylation predisposition. (D) Gene expression analysis for 599 
promoter CpG island associated genes predicted methylationprone and 996 predicted 
methylation-resistant genes in 52 cancer cell lines. Expression values were retrieved 
from a published work (Ross et al. 2000) and were analyzed as described in C. Only 
genes present in the studied array platforms could be evaluated, resulting in a different 
number of analyzed genes in each experiment.” Figure 9 was reproduced with 
permission from [38]. 
 
 Tables 5 and  Table 6 also show the top 50 genes predicted by our model as prone 
to methylation (methylation-prone) and resistant to methylation (methylation-resistant). In 
order to check the biological implications of our model, we compared the mRNA 
expression of predicted methylation-resistant and methylation-prone promoter CpG 
island genes in 52 human cancer cell lines and 28 normal differential human tissue using 
public microarray databases [25, 26].  
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Table 5: Top 50 predicted Methylation-prone genes (reproduced with permission 
from [38]). 
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Table 6: Top 50 predicted Methylation-resistant genes (reproduced with permission 
from [38]). 
 
As illustrated in Fig. 10-B and 10-D, genes predicted as methylation-resistant 
typically showed a lower expression in normal tissue than methylation-prone predicted 
genes, as would be expected if the model was correct due to the fact that silencing is 
correlated with hypermethylation of the promoter region. We also observed that genes 
predicted as prone to methylation were down regulated in cancer cell lines when 
compared to genes predicted as resistant to methylation (Fig. 10-C and 10-D). Therefore, 
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the depletion of these elements near the TSS is identified as an independent predictor of 
down regulation in cancer.  The cause of down regulation is likely due to the promoter 
CpG island methylation rather than the cell culture or even the cell type specific 
differences in gene expression, since cancer cell lines previously shown to have the 
highest degree of promoter CpG island methylation showed the lowest average 
expression of predicted methylation-prone genes (Fig. 10-E). 
In an interesting observation, we noted that non-CpG island promoter genes 
depleted of SINE and LINE retrotransposons were found to be moderately down 
regulated in cancer (Fig. 10-F).  
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Figure 10.” Genome architecture influences on PcG protein binding in embryonic and 
differentiated cells. (A) Frequency of predicted methylation groups among 
hyperconserved domains. (B) Relative contribution of hyperconserved domains and 
retrotransposon depletion in marking frequently methylated genes in cancer. MCAM data 
from 32 primary tissues and 28 cancer cell lines were averaged to identify frequently 
methylated genes. *Predicted status. (C ) Enrichment of H3K27me3 mark in predicted 
methylation-prone genes in cancer (PC3, prostate; MCF7, breast) and normal mortalized 
(PrEC, prostate epithelium) cell lines. H3K27me3 marking was measured by ChIP with 
microarray hybridization (ChIP-chip) and is quantified as log2 ratio of pull-down signal 
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over no antibody signal (Kondo et al. 2008). (D) Frequency of binding of SUZ12 and 
EED (PcG proteins) in human embryonic stem cells to 2583 methylation-resistant, 3655 
methylation-intermediate, and 1690 methylation-prone genes based on our predictive 
model. Note that genes predicted methylation-prone (thus depleted for SINE and LINE 
retrotransposons) are preferential targets of PcG proteins. (E ) Comparison of PcG 
marking and our predictive model in identifying methylation-prone genes from our 
training and first testing set. (F ) Average measuredmethylation of predicted methylation-
prone andmethylation-resistant genes in PcG marked genes. MCAM data from 32 
primary tumors and 28 cancer cell lines were averaged per comparison group, and 
methylation is presented as log2 ratio (cancer/control). The number of genes per 
category is presented above each column.” Figure 10 was reproduced with permission 
from [38]. 
 
Since the influence of non-CpG island promoter methylation on gene expression 
is limited, this result prompted us to ask the question does the genome architecture 
defined by SINE and LINE retrotransposons influence other epigenetic events besides 
DNA methylation? To address this question, we did a comparison of the presence of 
H3K27me3 between methylation resistant and methylation prone genes according to 
chromatin imprinted microarray results for 8727 gene promoters in 3 cell lines: PC3, a 
prostate cancer cell ; MCF7, a breast cancer cell line; and PrEC, an immortalized normal 
prostate epithelial cell line [27].  
Our work reveals a role for selected repetitive elements in determining polycomb 
group proteins targeting, aberrant DNA methylation, and gene expression in cancer. A 
paradoxical finding we noticed, was the depletion of the element SINE in genes prone to 
methylation, finding was paradoxical due to the fact that the main family of these 
elements (Alu family) were shown as nucleation centers in both plants and animals, and 
these repeats have been hypothesized to spread DNA methylation in Cancer [32]. 
However, we must take into account, that these repetitive elements have shown the 
opposite effect, such as working as insulator function [33, 34].  Despite this observation, 
the precise mechanism by which these repeat elements contribute to protection is 
unknown, it is likely that protection from de novo methylation is not directly mediated by 
these elements, but instead by transcription factors such as CTCF [35] and SP1 [36] 
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which contain euchromation/heterochromatin boundary activity. In such cases, genes 
lacking the binding sites for such boundary proteins would be adversely affected by the 
insertion of these elements near their promoters and therefore during evolution their 
presence was counter selected. In fact, it has been displayed that these elements when 
methylated are preferentially retained or inserted in gene-poor areas; this feature likely 
came about through negative selection [37]. Aside of the actual mechanism by which 
retrotransposons participate and are associated to the protection of de novo DNA 
methylation in cancer; our research suggests that the genomic architecture has a greater 
influence on disease and physiology than previously suspected.  
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Conclusion and Future Direction 
 
 
In recent years epigenetic modifications have been established as a key 
molecular signature in the progression of tumorigenesis. Discoveries, such as 
hypermethylation of the CpG island of certain tumor suppressor genes like BRAC1, link 
DNA methylation to the established genetic understanding for disruption of critical 
pathways in tumorigenesis. There range from apoptosis to DNA repair, cell cycle 
regulation and cellular adhesion. Therefore, hypermethylation of the promoter is now 
viewed as an established mechanism for gene inactivation.  A framework for 
understanding the possible relationship between mutational events and altered  DNA 
methylation is presented. A case is made here to show how retrotransposable elements, 
specifically LINEs and SINEs, are likely to function as key players a variety of toxicities, 
including but not limited to carcinogenesis. As it is known methylation plays an important 
role in supressing the gene activity of the inactive X chromosone in female mammals. 
Methylation also plays a role in suppression of transposable elements, for example Alu 
sequences within the gene. Speak on tumor supressor genes hypermethylation and and 
how hey disrupt and contribute to the disruption of many cell path ways. The genes p15, 
p14, and p16 on chromosone 9p21 are methylated in several cancers.   
 
Future direction upon this project is to use other algorithm and methods such as 
R-scan which is not restricted or is confined to a certain window. Development of a 
threshold which would allow for better separation of methylation-prone genes and 
methylation-resistant may create a more accurate using elements such as the 
retrotransposons mentioned in this report. Although this study had some flaws, such as 
threshold selection, predetermined windows, exclusion of other element (information) 
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that may strengthen its predictive power, the Positional Weight Matrix showed evidence 
of prediction with a high percentage value. Therefore, we found evidence that confirms 
our belief that the genomic architecture marked by retrotransposon elements does in fact 
play a part in the regulation of epigenetics. As for limitations of our research, to cite a 
few, are that we can not model selection (some genes are tumor suppressor genes and 
may be found methylated more frequently due their function in cancer, while oncogenes, 
once silenced, may lead to cell elimination) and that we can only predict methylation 
across multiple tissue, but not tissue-specific methylation. Therefore, we can better 
predict  genes that will be methylated in colon, breast or liver, but we cannot pick genes 
that are exclusively methylated in one specific tissue. In short, our model is a 
generalization of the microenvironment that allows for the de-novo methylation, but we 
do not identify the triggers of the process.  In conclusion, our findings help the field as a 
whole by showing that not only selection and gene function are at work in gene silencing, 
but also the gene microenvironment, and sheds light in the importance of genome 
organization in diseases. Also, our data supports previous work from Vertino, where 
some degree of concordance between repetitive elements and methylation was 
mentioned. It refutes the idea that histone marking is the most crucial marker of 
methylation-predisposition, as we show when comparing our method against H3K27me3.  
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